These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2354565)

  • 41. Expression of class II antigens in human renal allografts: comparison of acute rejection, chronic rejection, and cyclosporine nephrotoxicity.
    Toma H; Tanabe K; Oba S; Horita S; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1987 Oct; 19(5):3719-20. PubMed ID: 3313898
    [No Abstract]   [Full Text] [Related]  

  • 42. Cyclosporine-associated renal arteriopathy.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):151-7. PubMed ID: 3515683
    [No Abstract]   [Full Text] [Related]  

  • 43. Adult respiratory distress syndrome following intravenous cyclosporine.
    Bronsther O; Steiner R; Ward D; Gamboa E; Halasz N
    Clin Transpl; 1986; ():128. PubMed ID: 3154379
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of disopyramide in a cyclosporine-treated patient.
    Nanni G; Magalini SC; Serino F; Castagneto M
    Transplantation; 1988 Jan; 45(1):257. PubMed ID: 3276058
    [No Abstract]   [Full Text] [Related]  

  • 45. Parenchymal calcifications in the liver of kidney allograft recipients: an unrecognized side-effects of cyclosporine.
    Nanni G; De Gaetano AM; Boldrini G; Serino F; Pozzetto U; Magalini SC; Castagneto M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1558-9. PubMed ID: 2652506
    [No Abstract]   [Full Text] [Related]  

  • 46. Cyclosporine nephrotoxicity.
    Mihatsch MJ; Thiel G; Ryffel B
    Adv Nephrol Necker Hosp; 1988; 17():303-20. PubMed ID: 3124545
    [No Abstract]   [Full Text] [Related]  

  • 47. Morphological analysis of glomerular lesions in renal transplants immunosuppressed with cyclosporine A (CYA): has CYA induced a new transplant glomerular lesion?
    Morozumi K; Yoshida A; Suganuma T; Satoh K; Aoki J; Oikawa T; Fujinami T; Uchida K; Yamada N; Orihara A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):282-5. PubMed ID: 2650121
    [No Abstract]   [Full Text] [Related]  

  • 48. Urinary exfoliative cytology in kidney allografts under cyclosporine therapy.
    Cortesini R; Stella F; Renna Molajoni E; Lemeni AR; Rossi M; Pretagostini R; Alfani D
    Transplant Proc; 1984 Oct; 16(5):1200-1. PubMed ID: 6385377
    [No Abstract]   [Full Text] [Related]  

  • 49. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
    Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
    [No Abstract]   [Full Text] [Related]  

  • 50. Cyclosporine-associated nephrotoxicity is not intractable.
    Loertscher R
    Transplant Proc; 1987 Aug; 19(4):3486-9. PubMed ID: 3303520
    [No Abstract]   [Full Text] [Related]  

  • 51. Cyclosporine A interferes with postoperative blood glucose control after clinical pancreas transplantation.
    Baumgartner D; Schlumpf R; Largiadèr F
    Transplant Proc; 1987 Oct; 19(5):4009-10. PubMed ID: 3313987
    [No Abstract]   [Full Text] [Related]  

  • 52. Alterations in molecular structure of renal mitochondria associated with cyclosporine A treatment.
    Hay R; Tammi K; Ryffel B; Mihatsch MJ
    Clin Nephrol; 1986; 25 Suppl 1():S23-6. PubMed ID: 3011338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression.
    Raine AE; Carter R; Mann JI; Chapman JR; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1820-1. PubMed ID: 3274428
    [No Abstract]   [Full Text] [Related]  

  • 54. Morphological patterns in cyclosporine-treated renal transplant recipients.
    Mihatsch MJ; Thiel G; Basler V; Ryffel B; Landmann J; von Overbeck J; Zollinger HU
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):101-16. PubMed ID: 3895652
    [No Abstract]   [Full Text] [Related]  

  • 55. The mechanism of hyperuricaemia in cyclosporine-treated renal transplant recipients.
    Cohen SL; Boner G; Rosenfeld JB; Shmueli D; Sperling O; Yusim A; Todd-Pokropek A; Shapira Z
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1829-30. PubMed ID: 3079042
    [No Abstract]   [Full Text] [Related]  

  • 56. Cyclosporine-associated encephalopathy in childhood transplant patients.
    Lavenstein B; Stewart C; Tina LU
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):285-7. PubMed ID: 3291258
    [No Abstract]   [Full Text] [Related]  

  • 57. Cyclosporine-induced chronic nephropathy in human recipients of cardiac allografts.
    Moran M; Tomlanovich S; Myers BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):185-90. PubMed ID: 3895659
    [No Abstract]   [Full Text] [Related]  

  • 58. One hundred eighty graft biopsies in cyclosporine-treated kidney transplants.
    Yagisawa T; Takahashi K; Toma H; Teraoka S; Yamaguchi Y; Agishi T; Ota K
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):772-6. PubMed ID: 3291312
    [No Abstract]   [Full Text] [Related]  

  • 59. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study.
    Morales JM; Andrés A; Alvarez C; Prieto C; Ortuño B; Ortuño T; Paternina ER; Hernandez Poblete G; Praga M; Ruilope LM
    Transplant Proc; 1990 Aug; 22(4):1733-5. PubMed ID: 2389446
    [No Abstract]   [Full Text] [Related]  

  • 60. Is the vasoconstrictive effect of cyclosporine mediated by endothelin in kidney transplantation?
    Mouquet C; Benalia H; Carayon A; Bitker MO; Luciani J; Viars P
    Transplant Proc; 1994 Feb; 26(1):277-8. PubMed ID: 8108977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.